Matthew Taylor
Stock Analyst at Jefferies
(4.47)
# 1,154
Out of 4,662 analysts
661
Total ratings
56.1%
Success rate
7.6%
Average return
Main Sectors:
Stocks Rated by Matthew Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Maintained: Buy | $255 → $210 | $187.60 | +11.94% | 30 | Aug 6, 2026 | |
| GEHC GE HealthCare Technologies | Reiterated: Buy | $90 → $92 | $74.62 | +23.29% | 13 | Jul 30, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $67 | $52.01 | +28.82% | 52 | Jul 28, 2026 | |
| RMD ResMed | Maintained: Hold | $245 → $225 | $230.65 | -2.45% | 16 | Jul 10, 2026 | |
| SYK Stryker | Maintained: Buy | $465 → $455 | $339.98 | +33.83% | 35 | Jun 18, 2026 | |
| EW Edwards Lifesciences | Maintained: Buy | $102 | $92.28 | +10.53% | 68 | May 27, 2026 | |
| MDT Medtronic | Rated: Hold | $95 | $94.13 | +0.92% | 40 | Apr 24, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $145 → $135 | $114.43 | +17.98% | 42 | Apr 17, 2026 | |
| LNTH Lantheus Holdings | Reiterated: Buy | $105 → $110 | $100.48 | +9.47% | 13 | Mar 18, 2026 | |
| PODD Insulet | Reiterated: Buy | $400 | $151.51 | +164.01% | 30 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $112 | $89.88 | +24.61% | 36 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $26.64 | -28.68% | 34 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $115 | $88.34 | +30.18% | 30 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $23.46 | +104.60% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $15 → $12 | $18.46 | -34.99% | 3 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $23.26 | -18.31% | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $130 → $110 | $100.74 | n/a | 28 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $79 → $80 | $80.84 | n/a | 13 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $61 → $63 | $75.36 | n/a | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $19.91 | n/a | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $397.72 | n/a | 24 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $215 → $145 | $135.86 | n/a | 32 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33.00 → $34.50 | $17.93 | n/a | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $16 → $15 | $15.04 | n/a | 23 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.5 → $6 | $9.11 | n/a | 3 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $17.24 | n/a | 16 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $105 | $51.25 | n/a | 1 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $14 | $5.55 | n/a | 1 | Jan 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 364.00 → CHF 255.00 | CHF 241.80 | n/a | 13 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $230 | $326.84 | n/a | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $5.5 | $9.17 | n/a | 2 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $213.00 | n/a | 2 | Feb 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €49.00 | €23.59 | n/a | 21 | Jan 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $39.98 | n/a | 1 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $1.5 → $1 | $7.27 | n/a | 9 | Mar 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $16 | $16.07 | n/a | 2 | Jul 19, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $2.5 | $0.000001 | n/a | 2 | May 12, 2016 |
Becton, Dickinson and Company
Aug 6, 2026
Maintained: Buy
Price Target: $255 → $210
Current: $187.60
Upside: +11.94%
GE HealthCare Technologies
Jul 30, 2026
Reiterated: Buy
Price Target: $90 → $92
Current: $74.62
Upside: +23.29%
Boston Scientific
Jul 28, 2026
Maintained: Buy
Price Target: $67
Current: $52.01
Upside: +28.82%
ResMed
Jul 10, 2026
Maintained: Hold
Price Target: $245 → $225
Current: $230.65
Upside: -2.45%
Stryker
Jun 18, 2026
Maintained: Buy
Price Target: $465 → $455
Current: $339.98
Upside: +33.83%
Edwards Lifesciences
May 27, 2026
Maintained: Buy
Price Target: $102
Current: $92.28
Upside: +10.53%
Medtronic
Apr 24, 2026
Rated: Hold
Price Target: $95
Current: $94.13
Upside: +0.92%
Abbott Laboratories
Apr 17, 2026
Reiterated: Buy
Price Target: $145 → $135
Current: $114.43
Upside: +17.98%
Lantheus Holdings
Mar 18, 2026
Reiterated: Buy
Price Target: $105 → $110
Current: $100.48
Upside: +9.47%
Insulet
Feb 19, 2026
Reiterated: Buy
Price Target: $400
Current: $151.51
Upside: +164.01%
Feb 13, 2026
Reiterated: Buy
Price Target: $112
Current: $89.88
Upside: +24.61%
Feb 12, 2026
Reiterated: Hold
Price Target: $19
Current: $26.64
Upside: -28.68%
Jan 8, 2026
Reiterated: Buy
Price Target: $105 → $115
Current: $88.34
Upside: +30.18%
Nov 7, 2025
Reiterated: Buy
Price Target: $48
Current: $23.46
Upside: +104.60%
Oct 3, 2025
Maintained: Hold
Price Target: $15 → $12
Current: $18.46
Upside: -34.99%
Aug 25, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $23.26
Upside: -18.31%
Aug 7, 2025
Maintained: Hold
Price Target: $130 → $110
Current: $100.74
Upside: n/a
Aug 7, 2025
Maintained: Buy
Price Target: $79 → $80
Current: $80.84
Upside: n/a
Aug 7, 2025
Maintained: Buy
Price Target: $61 → $63
Current: $75.36
Upside: n/a
Aug 5, 2025
Maintained: Buy
Price Target: $28
Current: $19.91
Upside: n/a
May 2, 2025
Maintained: Hold
Price Target: n/a
Current: $397.72
Upside: n/a
May 1, 2025
Reiterated: Hold
Price Target: $215 → $145
Current: $135.86
Upside: n/a
Apr 28, 2025
Maintained: Buy
Price Target: $33.00 → $34.50
Current: $17.93
Upside: n/a
Apr 14, 2025
Upgraded: Buy
Price Target: $16 → $15
Current: $15.04
Upside: n/a
Mar 4, 2025
Reiterated: Sell
Price Target: $0.5 → $6
Current: $9.11
Upside: n/a
Jul 16, 2024
Reiterated: Buy
Price Target: $50 → $48
Current: $17.24
Upside: n/a
Feb 1, 2024
Maintained: Hold
Price Target: $105
Current: $51.25
Upside: n/a
Jan 19, 2024
Initiated Coverage: Buy
Price Target: $14
Current: $5.55
Upside: n/a
Oct 28, 2022
Maintained: Hold
Price Target: CHF 364.00 → CHF 255.00
Current: CHF 241.80
Upside: n/a
Oct 12, 2022
Initiated Coverage: Buy
Price Target: $230
Current: $326.84
Upside: n/a
Mar 1, 2022
Maintained: Hold
Price Target: $7 → $5.5
Current: $9.17
Upside: n/a
Feb 7, 2022
Upgraded: Buy
Price Target: n/a
Current: $213.00
Upside: n/a
Jan 25, 2022
Maintained: Buy
Price Target: €49.00
Current: €23.59
Upside: n/a
Dec 6, 2019
Maintained: Hold
Price Target: n/a
Current: $39.98
Upside: n/a
Mar 8, 2018
Maintained: Sell
Price Target: $1.5 → $1
Current: $7.27
Upside: n/a
Jul 19, 2017
Maintained: Hold
Price Target: $17 → $16
Current: $16.07
Upside: n/a
May 12, 2016
Reiterated: Hold
Price Target: $5 → $2.5
Current: $0.000001
Upside: n/a